Clinical Trial Update: Rifaximin for Functional Dyspepsia [Phase 2, Phase 3]

View source ↗

Summary

This update notes completion of Phase 2 and Phase 3 clinical trials evaluating rifaximin for functional dyspepsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: The University of Hong Kong | Conditions: Functional Dyspepsia | Phase 2, Phase 3 | Status: COMPLETED